| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thermogenesis | 42 | 2024 | 494 | 11.030 |
Why?
|
| Adipose Tissue, Brown | 59 | 2022 | 776 | 8.920 |
Why?
|
| Adipocytes | 81 | 2024 | 1199 | 8.780 |
Why?
|
| Transcription Factors | 180 | 2023 | 12171 | 5.920 |
Why?
|
| Adipose Tissue | 100 | 2023 | 3334 | 5.530 |
Why?
|
| Trans-Activators | 58 | 2013 | 2857 | 5.270 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 66 | 2013 | 859 | 5.100 |
Why?
|
| Energy Metabolism | 52 | 2024 | 2907 | 3.640 |
Why?
|
| Creatine | 9 | 2024 | 427 | 3.470 |
Why?
|
| Fibronectins | 14 | 2024 | 722 | 3.330 |
Why?
|
| PPAR gamma | 20 | 2020 | 487 | 3.200 |
Why?
|
| Thiazolidinediones | 27 | 2020 | 461 | 2.610 |
Why?
|
| Mitochondria | 36 | 2024 | 3683 | 2.410 |
Why?
|
| DNA-Binding Proteins | 69 | 2016 | 9617 | 2.300 |
Why?
|
| Gene Expression Regulation | 96 | 2022 | 11930 | 2.270 |
Why?
|
| Physical Conditioning, Animal | 14 | 2021 | 363 | 2.230 |
Why?
|
| Muscle, Skeletal | 44 | 2024 | 4978 | 2.170 |
Why?
|
| Obesity | 70 | 2024 | 13091 | 2.060 |
Why?
|
| Mice | 254 | 2024 | 82049 | 1.900 |
Why?
|
| Animals | 320 | 2024 | 169285 | 1.760 |
Why?
|
| Cachexia | 6 | 2019 | 202 | 1.740 |
Why?
|
| Transcription, Genetic | 53 | 2015 | 7609 | 1.710 |
Why?
|
| Adipose Tissue, White | 11 | 2020 | 371 | 1.680 |
Why?
|
| Cell Differentiation | 94 | 2020 | 11677 | 1.600 |
Why?
|
| Gluconeogenesis | 11 | 2011 | 185 | 1.560 |
Why?
|
| Mitochondrial Proteins | 24 | 2021 | 979 | 1.550 |
Why?
|
| Heat-Shock Proteins | 10 | 2013 | 797 | 1.350 |
Why?
|
| Adipocytes, Brown | 7 | 2018 | 160 | 1.340 |
Why?
|
| Ion Channels | 21 | 2016 | 1043 | 1.300 |
Why?
|
| Insulin Resistance | 34 | 2021 | 3986 | 1.300 |
Why?
|
| Muscle Fibers, Skeletal | 7 | 2014 | 553 | 1.250 |
Why?
|
| Amidohydrolases | 3 | 2020 | 160 | 1.230 |
Why?
|
| Mice, Knockout | 50 | 2024 | 14488 | 1.210 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 24 | 2005 | 288 | 1.180 |
Why?
|
| Glucose | 25 | 2021 | 4352 | 1.170 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2014 | 615 | 1.170 |
Why?
|
| Reactive Oxygen Species | 8 | 2020 | 2152 | 1.160 |
Why?
|
| 3T3 Cells | 37 | 2014 | 1084 | 1.140 |
Why?
|
| Sympathetic Nervous System | 2 | 2020 | 521 | 1.080 |
Why?
|
| Transcriptional Activation | 25 | 2014 | 1750 | 1.040 |
Why?
|
| Cysteine | 3 | 2021 | 897 | 1.000 |
Why?
|
| Cyclin-Dependent Kinase 5 | 4 | 2014 | 110 | 0.990 |
Why?
|
| Nerve Tissue Proteins | 19 | 2020 | 4413 | 0.980 |
Why?
|
| Signal Transduction | 29 | 2024 | 23648 | 0.980 |
Why?
|
| Cold Temperature | 10 | 2021 | 791 | 0.970 |
Why?
|
| Carcinoma, Lewis Lung | 2 | 2015 | 108 | 0.950 |
Why?
|
| Cells, Cultured | 56 | 2020 | 19025 | 0.950 |
Why?
|
| Homeostasis | 21 | 2021 | 3348 | 0.930 |
Why?
|
| Serine Endopeptidases | 23 | 1996 | 1027 | 0.920 |
Why?
|
| Liver | 26 | 2021 | 7578 | 0.910 |
Why?
|
| Mice, Inbred C57BL | 54 | 2024 | 22380 | 0.910 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 7 | 2024 | 693 | 0.900 |
Why?
|
| Adipogenesis | 5 | 2020 | 371 | 0.900 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 6 | 2010 | 102 | 0.870 |
Why?
|
| Saposins | 1 | 2023 | 22 | 0.840 |
Why?
|
| Cell Respiration | 9 | 2017 | 201 | 0.840 |
Why?
|
| Tumor Necrosis Factor-alpha | 17 | 2011 | 4355 | 0.830 |
Why?
|
| Mice, Transgenic | 41 | 2020 | 9561 | 0.820 |
Why?
|
| Insulin | 36 | 2019 | 6610 | 0.820 |
Why?
|
| Mitochondria, Muscle | 9 | 2023 | 172 | 0.820 |
Why?
|
| Complement Factor D | 24 | 2019 | 67 | 0.820 |
Why?
|
| MAP Kinase Signaling System | 7 | 2024 | 1495 | 0.810 |
Why?
|
| Alkaline Phosphatase | 2 | 2024 | 864 | 0.780 |
Why?
|
| Ligands | 26 | 2019 | 3284 | 0.770 |
Why?
|
| Carrier Proteins | 25 | 2006 | 4939 | 0.770 |
Why?
|
| Gene Expression Regulation, Developmental | 13 | 2013 | 3610 | 0.770 |
Why?
|
| Cell Line | 56 | 2024 | 15602 | 0.770 |
Why?
|
| RNA, Messenger | 60 | 2014 | 12801 | 0.760 |
Why?
|
| Extracellular Fluid | 1 | 2023 | 165 | 0.760 |
Why?
|
| Osteocytes | 2 | 2024 | 193 | 0.760 |
Why?
|
| Phosphocreatine | 2 | 2022 | 261 | 0.750 |
Why?
|
| Thiazoles | 21 | 2010 | 1542 | 0.740 |
Why?
|
| Nuclear Proteins | 32 | 2004 | 5804 | 0.730 |
Why?
|
| Cell Communication | 2 | 2023 | 1660 | 0.690 |
Why?
|
| Neoplasm Proteins | 15 | 2008 | 3604 | 0.660 |
Why?
|
| Integrin alphaV | 1 | 2018 | 54 | 0.630 |
Why?
|
| Oleic Acids | 1 | 2018 | 71 | 0.600 |
Why?
|
| Muscle Proteins | 5 | 2016 | 1165 | 0.600 |
Why?
|
| Amidinotransferases | 1 | 2017 | 11 | 0.590 |
Why?
|
| 5' Untranslated Regions | 1 | 2019 | 255 | 0.580 |
Why?
|
| Muscle Fibers, Slow-Twitch | 3 | 2010 | 52 | 0.580 |
Why?
|
| Gene Expression | 23 | 2021 | 7601 | 0.580 |
Why?
|
| Receptors, Adrenergic | 1 | 2017 | 155 | 0.570 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2017 | 57 | 0.570 |
Why?
|
| Receptors, Estrogen | 9 | 2013 | 2253 | 0.560 |
Why?
|
| Muscle Fibers, Fast-Twitch | 2 | 2007 | 71 | 0.560 |
Why?
|
| Selenium | 1 | 2020 | 418 | 0.560 |
Why?
|
| Acclimatization | 1 | 2017 | 113 | 0.550 |
Why?
|
| Diabetes Mellitus, Experimental | 9 | 2010 | 1124 | 0.550 |
Why?
|
| Insulin-Secreting Cells | 3 | 2019 | 899 | 0.550 |
Why?
|
| Osteolysis | 1 | 2018 | 274 | 0.550 |
Why?
|
| Fibroblast Growth Factors | 3 | 2012 | 873 | 0.540 |
Why?
|
| Fats | 2 | 2016 | 99 | 0.540 |
Why?
|
| Electron Transport | 1 | 2017 | 211 | 0.540 |
Why?
|
| Phosphorylation | 22 | 2020 | 8316 | 0.530 |
Why?
|
| Parathyroid Hormone-Related Protein | 2 | 2015 | 327 | 0.530 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2021 | 1657 | 0.530 |
Why?
|
| Open Reading Frames | 2 | 2019 | 818 | 0.530 |
Why?
|
| Adaptation, Physiological | 6 | 2013 | 1312 | 0.510 |
Why?
|
| Transfection | 28 | 2007 | 5756 | 0.510 |
Why?
|
| Heme | 2 | 2009 | 316 | 0.510 |
Why?
|
| Genes, fos | 10 | 1998 | 176 | 0.500 |
Why?
|
| TRPV Cation Channels | 2 | 2018 | 244 | 0.490 |
Why?
|
| Base Sequence | 46 | 2009 | 12422 | 0.490 |
Why?
|
| Glutamine | 1 | 2018 | 577 | 0.490 |
Why?
|
| Subcutaneous Fat | 3 | 2019 | 404 | 0.480 |
Why?
|
| Bone Remodeling | 1 | 2018 | 583 | 0.480 |
Why?
|
| Enhancer Elements, Genetic | 11 | 2004 | 1367 | 0.480 |
Why?
|
| Promoter Regions, Genetic | 31 | 2008 | 5797 | 0.470 |
Why?
|
| Molecular Sequence Data | 41 | 2015 | 17623 | 0.470 |
Why?
|
| Gene Expression Profiling | 14 | 2014 | 9540 | 0.470 |
Why?
|
| Calcium-Binding Proteins | 2 | 2019 | 1083 | 0.460 |
Why?
|
| Receptors, Retinoic Acid | 8 | 1999 | 229 | 0.460 |
Why?
|
| Fibroblasts | 13 | 2009 | 4178 | 0.460 |
Why?
|
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2015 | 305 | 0.450 |
Why?
|
| Cell Division | 14 | 2007 | 4477 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 13 | 2023 | 12252 | 0.450 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2018 | 605 | 0.450 |
Why?
|
| Glucose Tolerance Test | 9 | 2016 | 1183 | 0.440 |
Why?
|
| Interleukin-17 | 1 | 2020 | 924 | 0.440 |
Why?
|
| Science | 2 | 2010 | 236 | 0.440 |
Why?
|
| Fasting | 8 | 2013 | 1610 | 0.440 |
Why?
|
| Oxidative Phosphorylation | 5 | 2017 | 501 | 0.440 |
Why?
|
| Histone Demethylases | 1 | 2016 | 328 | 0.430 |
Why?
|
| Lipid Metabolism | 9 | 2021 | 1904 | 0.430 |
Why?
|
| Oxidation-Reduction | 8 | 2018 | 2227 | 0.430 |
Why?
|
| Complement C3a | 3 | 2019 | 66 | 0.420 |
Why?
|
| Organ Specificity | 14 | 2020 | 1968 | 0.420 |
Why?
|
| Hepatocytes | 6 | 2013 | 1247 | 0.410 |
Why?
|
| Metabolic Diseases | 4 | 2015 | 684 | 0.410 |
Why?
|
| Oxygen Consumption | 10 | 2019 | 1880 | 0.410 |
Why?
|
| Carboplatin | 3 | 2018 | 797 | 0.400 |
Why?
|
| Male | 96 | 2024 | 364731 | 0.400 |
Why?
|
| Glycerides | 4 | 1993 | 67 | 0.400 |
Why?
|
| Stem Cells | 10 | 2020 | 3538 | 0.400 |
Why?
|
| Resistance Training | 3 | 2016 | 198 | 0.400 |
Why?
|
| Exercise | 9 | 2024 | 5954 | 0.400 |
Why?
|
| Fatty Acids | 13 | 2019 | 1812 | 0.390 |
Why?
|
| Receptors, Tumor Necrosis Factor | 6 | 1997 | 588 | 0.390 |
Why?
|
| Amino Acid Sequence | 24 | 2016 | 13422 | 0.390 |
Why?
|
| Receptor, Insulin | 7 | 2001 | 839 | 0.390 |
Why?
|
| Neurodegenerative Diseases | 5 | 2007 | 1094 | 0.390 |
Why?
|
| Forkhead Transcription Factors | 7 | 2011 | 1625 | 0.380 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 14 | 2005 | 136 | 0.380 |
Why?
|
| Nerve Growth Factors | 1 | 2014 | 564 | 0.370 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2004 | 1246 | 0.370 |
Why?
|
| Activating Transcription Factor 6 | 1 | 2011 | 31 | 0.370 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2011 | 203 | 0.360 |
Why?
|
| Cell Biology | 1 | 2011 | 92 | 0.360 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2011 | 183 | 0.360 |
Why?
|
| Mice, Obese | 8 | 2016 | 418 | 0.360 |
Why?
|
| Phosphoproteins | 10 | 2008 | 2451 | 0.350 |
Why?
|
| Dietary Fats | 8 | 2012 | 2003 | 0.350 |
Why?
|
| Rats | 30 | 2018 | 23782 | 0.350 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 3 | 2006 | 127 | 0.350 |
Why?
|
| Humans | 141 | 2024 | 768171 | 0.350 |
Why?
|
| Hormones | 7 | 2021 | 866 | 0.350 |
Why?
|
| Glucocorticoids | 4 | 2016 | 2167 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-jun | 11 | 1996 | 287 | 0.340 |
Why?
|
| Hypoglycemic Agents | 15 | 2011 | 3109 | 0.340 |
Why?
|
| Nuclear Receptor Subfamily 1, Group D, Member 1 | 1 | 2009 | 33 | 0.340 |
Why?
|
| Muscles | 8 | 2023 | 1582 | 0.340 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 931 | 0.340 |
Why?
|
| Myoblasts | 3 | 2013 | 234 | 0.340 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 812 | 0.340 |
Why?
|
| Cloning, Molecular | 13 | 2000 | 4168 | 0.330 |
Why?
|
| Diabetes Mellitus | 11 | 2014 | 5891 | 0.330 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 2015 | 1730 | 0.330 |
Why?
|
| Chromans | 8 | 2003 | 116 | 0.330 |
Why?
|
| Physiology | 1 | 2010 | 112 | 0.320 |
Why?
|
| Pericytes | 1 | 2012 | 299 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-fos | 15 | 1998 | 580 | 0.320 |
Why?
|
| Adipokines | 3 | 2023 | 309 | 0.320 |
Why?
|
| Parathyroid Hormone | 1 | 2015 | 1804 | 0.320 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2015 | 1197 | 0.320 |
Why?
|
| Unfolded Protein Response | 1 | 2011 | 239 | 0.310 |
Why?
|
| Multienzyme Complexes | 3 | 2007 | 664 | 0.310 |
Why?
|
| Myosin Heavy Chains | 3 | 2014 | 404 | 0.310 |
Why?
|
| Proto-Oncogenes | 5 | 1990 | 322 | 0.310 |
Why?
|
| Membrane Proteins | 9 | 2019 | 7876 | 0.310 |
Why?
|
| HEK293 Cells | 6 | 2019 | 4280 | 0.300 |
Why?
|
| Cyclic AMP | 11 | 2021 | 1470 | 0.300 |
Why?
|
| Protein Binding | 14 | 2020 | 9343 | 0.290 |
Why?
|
| Phosphoserine | 4 | 2014 | 204 | 0.290 |
Why?
|
| Microtubules | 6 | 2008 | 1064 | 0.290 |
Why?
|
| DNA Damage | 1 | 2018 | 2469 | 0.290 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2008 | 164 | 0.290 |
Why?
|
| Tubulin Modulators | 1 | 2008 | 106 | 0.290 |
Why?
|
| Glycoproteins | 6 | 2000 | 2202 | 0.280 |
Why?
|
| Muscular Atrophy | 3 | 2024 | 335 | 0.280 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 5 | 2003 | 492 | 0.280 |
Why?
|
| Cell Lineage | 4 | 2015 | 2575 | 0.280 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1247 | 0.280 |
Why?
|
| Temperature | 2 | 2013 | 2234 | 0.280 |
Why?
|
| Colonic Neoplasms | 4 | 2005 | 2541 | 0.270 |
Why?
|
| Proto-Oncogene Proteins | 10 | 2022 | 4528 | 0.270 |
Why?
|
| Body Temperature Regulation | 4 | 2000 | 292 | 0.270 |
Why?
|
| Triglycerides | 7 | 2009 | 2464 | 0.260 |
Why?
|
| Adipocytes, White | 4 | 2014 | 92 | 0.260 |
Why?
|
| Gene Expression Regulation, Enzymologic | 7 | 2001 | 1169 | 0.260 |
Why?
|
| Recombinant Proteins | 16 | 2013 | 6512 | 0.260 |
Why?
|
| Blood Proteins | 3 | 2020 | 1191 | 0.260 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 4 | 2013 | 500 | 0.260 |
Why?
|
| Neurons | 6 | 2019 | 9514 | 0.260 |
Why?
|
| Glucose-6-Phosphatase | 3 | 2016 | 71 | 0.260 |
Why?
|
| Hippocampus | 4 | 2018 | 3783 | 0.260 |
Why?
|
| Porphyrias | 1 | 2005 | 57 | 0.250 |
Why?
|
| Enzyme Activation | 5 | 2016 | 3590 | 0.250 |
Why?
|
| Leigh Disease | 1 | 2006 | 89 | 0.250 |
Why?
|
| COS Cells | 5 | 2011 | 1135 | 0.250 |
Why?
|
| Helix-Loop-Helix Motifs | 4 | 1998 | 97 | 0.250 |
Why?
|
| Cardiac Output, Low | 1 | 2006 | 192 | 0.250 |
Why?
|
| Blotting, Northern | 10 | 1997 | 1553 | 0.240 |
Why?
|
| Hypertrophy | 3 | 2024 | 562 | 0.240 |
Why?
|
| Protein Structure, Tertiary | 6 | 2011 | 3772 | 0.240 |
Why?
|
| Interferon Regulatory Factors | 2 | 2018 | 271 | 0.240 |
Why?
|
| Cell Line, Transformed | 6 | 2006 | 866 | 0.240 |
Why?
|
| Protein Isoforms | 7 | 2022 | 1715 | 0.240 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2024 | 29 | 0.240 |
Why?
|
| Myostatin | 2 | 2018 | 129 | 0.240 |
Why?
|
| Endopeptidases | 6 | 1987 | 764 | 0.240 |
Why?
|
| Oxidative Stress | 4 | 2013 | 3140 | 0.230 |
Why?
|
| Binding Sites | 14 | 2007 | 6019 | 0.230 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1143 | 0.230 |
Why?
|
| Neuromuscular Junction | 1 | 2007 | 407 | 0.230 |
Why?
|
| Genes, Regulator | 5 | 2008 | 373 | 0.230 |
Why?
|
| Hyperkinesis | 1 | 2004 | 88 | 0.230 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2007 | 271 | 0.230 |
Why?
|
| Insulin-Like Growth Factor I | 3 | 2020 | 1942 | 0.230 |
Why?
|
| Protons | 4 | 2019 | 1113 | 0.220 |
Why?
|
| Muscle Cells | 3 | 2012 | 195 | 0.220 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 4 | 2001 | 40 | 0.220 |
Why?
|
| Antineoplastic Agents | 6 | 2018 | 13677 | 0.220 |
Why?
|
| Culture Media, Conditioned | 3 | 2014 | 521 | 0.220 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 10266 | 0.220 |
Why?
|
| Interleukin-15 | 1 | 2024 | 186 | 0.220 |
Why?
|
| Lipoproteins | 2 | 2020 | 880 | 0.220 |
Why?
|
| Growth Substances | 5 | 1997 | 760 | 0.220 |
Why?
|
| Membrane Transport Proteins | 2 | 2019 | 1037 | 0.220 |
Why?
|
| Blood Glucose | 9 | 2016 | 6431 | 0.210 |
Why?
|
| Inflammation | 9 | 2021 | 10873 | 0.210 |
Why?
|
| GA-Binding Protein Transcription Factor | 4 | 2007 | 43 | 0.210 |
Why?
|
| Exercise Test | 2 | 2016 | 2186 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 9 | 2016 | 6231 | 0.210 |
Why?
|
| Retinoid X Receptors | 8 | 1999 | 91 | 0.210 |
Why?
|
| Fatty Acid-Binding Proteins | 12 | 1996 | 294 | 0.210 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 2 | 2016 | 14 | 0.210 |
Why?
|
| Angiogenesis Inducing Agents | 4 | 1993 | 254 | 0.210 |
Why?
|
| Transcription Factor AP-1 | 4 | 1997 | 321 | 0.200 |
Why?
|
| Cell Separation | 3 | 2017 | 1728 | 0.200 |
Why?
|
| Glycerolphosphate Dehydrogenase | 7 | 1987 | 40 | 0.200 |
Why?
|
| Amino Acids | 3 | 2020 | 1716 | 0.200 |
Why?
|
| Proteins | 7 | 2005 | 6009 | 0.200 |
Why?
|
| STAT3 Transcription Factor | 2 | 2020 | 874 | 0.200 |
Why?
|
| Genes, APC | 1 | 2002 | 145 | 0.200 |
Why?
|
| Cytoskeletal Proteins | 2 | 2005 | 1327 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 9 | 2016 | 6082 | 0.200 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2012 | 393 | 0.200 |
Why?
|
| Models, Biological | 10 | 2010 | 9497 | 0.190 |
Why?
|
| Lipoma | 2 | 1995 | 296 | 0.190 |
Why?
|
| Heart | 2 | 2015 | 4446 | 0.190 |
Why?
|
| RNA, Small Interfering | 7 | 2013 | 3428 | 0.190 |
Why?
|
| Myelin P2 Protein | 4 | 1996 | 20 | 0.190 |
Why?
|
| DNA | 15 | 1996 | 7213 | 0.190 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2021 | 7 | 0.190 |
Why?
|
| Muscle Development | 3 | 2008 | 258 | 0.190 |
Why?
|
| Complement System Proteins | 2 | 1996 | 738 | 0.190 |
Why?
|
| Protein Conformation | 5 | 2013 | 3956 | 0.190 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2002 | 130 | 0.190 |
Why?
|
| Fatty Liver | 3 | 2021 | 810 | 0.190 |
Why?
|
| Hyperlipidemias | 2 | 2005 | 772 | 0.190 |
Why?
|
| Mice, Nude | 4 | 2018 | 3623 | 0.190 |
Why?
|
| Endothelial Growth Factors | 2 | 1995 | 672 | 0.180 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2020 | 11 | 0.180 |
Why?
|
| Adenosine Triphosphate | 6 | 2019 | 2004 | 0.180 |
Why?
|
| Myogenic Regulatory Factors | 4 | 2003 | 102 | 0.180 |
Why?
|
| Atrophy | 2 | 2016 | 1646 | 0.180 |
Why?
|
| Microbodies | 2 | 1997 | 34 | 0.180 |
Why?
|
| Microvascular Angina | 1 | 2000 | 14 | 0.180 |
Why?
|
| 3T3-L1 Cells | 4 | 2011 | 208 | 0.180 |
Why?
|
| GTP-Binding Proteins | 3 | 1995 | 948 | 0.180 |
Why?
|
| Nuclear Respiratory Factors | 4 | 2001 | 18 | 0.180 |
Why?
|
| Hydrolysis | 2 | 2021 | 646 | 0.180 |
Why?
|
| Neovascularization, Physiologic | 1 | 2008 | 1370 | 0.180 |
Why?
|
| Gene Knockdown Techniques | 3 | 2014 | 1606 | 0.180 |
Why?
|
| Lymphokines | 2 | 1995 | 925 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor A | 4 | 2016 | 3517 | 0.180 |
Why?
|
| Cell Line, Tumor | 6 | 2019 | 17142 | 0.180 |
Why?
|
| Neprilysin | 1 | 2023 | 487 | 0.180 |
Why?
|
| Bone Resorption | 2 | 2024 | 728 | 0.180 |
Why?
|
| ADP-Ribosylation Factors | 4 | 1995 | 131 | 0.170 |
Why?
|
| Isoenzymes | 4 | 2014 | 1688 | 0.170 |
Why?
|
| Islets of Langerhans | 2 | 2003 | 1351 | 0.170 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2020 | 120 | 0.170 |
Why?
|
| Muscle Strength | 1 | 2024 | 640 | 0.170 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2019 | 47 | 0.170 |
Why?
|
| Mitochondrial ADP, ATP Translocases | 1 | 2019 | 11 | 0.170 |
Why?
|
| Corpus Striatum | 2 | 2022 | 1224 | 0.170 |
Why?
|
| Monosaccharide Transport Proteins | 2 | 2001 | 437 | 0.170 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2019 | 71 | 0.170 |
Why?
|
| Genetic Vectors | 9 | 2013 | 3403 | 0.170 |
Why?
|
| Tuna | 1 | 2019 | 18 | 0.170 |
Why?
|
| Computational Biology | 1 | 2011 | 3567 | 0.170 |
Why?
|
| Epoxy Compounds | 1 | 2000 | 137 | 0.160 |
Why?
|
| Kininogens | 1 | 2019 | 15 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 9 | 2005 | 6124 | 0.160 |
Why?
|
| Oxygen | 5 | 2011 | 4270 | 0.160 |
Why?
|
| Female | 49 | 2024 | 397187 | 0.160 |
Why?
|
| Amino Acid Motifs | 2 | 2018 | 930 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2021 | 687 | 0.160 |
Why?
|
| Diptera | 1 | 2019 | 50 | 0.160 |
Why?
|
| Osteoblasts | 2 | 2020 | 1153 | 0.160 |
Why?
|
| Ischemia | 1 | 2008 | 1900 | 0.160 |
Why?
|
| Body Temperature | 3 | 2018 | 780 | 0.160 |
Why?
|
| Macrophages | 3 | 2014 | 5802 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2012 | 3589 | 0.160 |
Why?
|
| Kinetics | 13 | 2013 | 6330 | 0.160 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 840 | 0.160 |
Why?
|
| Adenosine Diphosphate | 2 | 2019 | 422 | 0.150 |
Why?
|
| Adenoviridae | 5 | 2013 | 1093 | 0.150 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2015 | 1535 | 0.150 |
Why?
|
| Biological Transport | 2 | 2019 | 2085 | 0.150 |
Why?
|
| Myocytes, Cardiac | 3 | 2015 | 1682 | 0.150 |
Why?
|
| Rats, Zucker | 5 | 2003 | 131 | 0.150 |
Why?
|
| Insulin Receptor Substrate Proteins | 5 | 1999 | 558 | 0.150 |
Why?
|
| Cytochromes c | 3 | 2007 | 173 | 0.150 |
Why?
|
| Neurites | 2 | 2019 | 389 | 0.150 |
Why?
|
| Liposarcoma | 2 | 1999 | 289 | 0.150 |
Why?
|
| Genes, jun | 2 | 1996 | 69 | 0.140 |
Why?
|
| 5-Aminolevulinate Synthetase | 2 | 2009 | 64 | 0.140 |
Why?
|
| Basal Metabolism | 2 | 2017 | 163 | 0.140 |
Why?
|
| Repressor Proteins | 3 | 2004 | 2982 | 0.140 |
Why?
|
| Tubulin | 6 | 1983 | 695 | 0.140 |
Why?
|
| Neoplasms | 4 | 2023 | 22371 | 0.140 |
Why?
|
| Models, Molecular | 4 | 2011 | 5402 | 0.140 |
Why?
|
| Quadriceps Muscle | 1 | 2018 | 157 | 0.140 |
Why?
|
| RNA Splicing | 2 | 2000 | 905 | 0.140 |
Why?
|
| Myocardium | 3 | 2010 | 4790 | 0.140 |
Why?
|
| Mutation | 20 | 2019 | 30237 | 0.140 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2016 | 29 | 0.140 |
Why?
|
| Transgenes | 5 | 2010 | 1016 | 0.140 |
Why?
|
| Immunoprecipitation | 1 | 2019 | 874 | 0.140 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 858 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 10 | 2003 | 3740 | 0.130 |
Why?
|
| Osteoclasts | 1 | 2020 | 713 | 0.130 |
Why?
|
| Retinoids | 1 | 1997 | 99 | 0.130 |
Why?
|
| Mentors | 1 | 2002 | 671 | 0.130 |
Why?
|
| Norepinephrine | 2 | 2016 | 898 | 0.130 |
Why?
|
| Osteogenesis | 3 | 2020 | 1295 | 0.130 |
Why?
|
| Crosses, Genetic | 3 | 2009 | 752 | 0.130 |
Why?
|
| Cytokines | 5 | 2011 | 7452 | 0.130 |
Why?
|
| Genes, Reporter | 6 | 2007 | 1524 | 0.130 |
Why?
|
| Hypothalamus | 3 | 2001 | 1004 | 0.130 |
Why?
|
| Genes, Lethal | 2 | 1993 | 224 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2023 | 3115 | 0.130 |
Why?
|
| Arteriosclerosis | 1 | 2000 | 1055 | 0.130 |
Why?
|
| Protein Biosynthesis | 5 | 2008 | 2094 | 0.130 |
Why?
|
| Cell Nucleus | 8 | 2008 | 2885 | 0.130 |
Why?
|
| Leptin | 7 | 2003 | 1599 | 0.130 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 642 | 0.130 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 1996 | 83 | 0.130 |
Why?
|
| Genes, abl | 1 | 1995 | 69 | 0.130 |
Why?
|
| Antigens, CD | 2 | 1997 | 4035 | 0.130 |
Why?
|
| Gene Deletion | 4 | 2021 | 2674 | 0.130 |
Why?
|
| Drosophila | 1 | 2023 | 1513 | 0.130 |
Why?
|
| Genes | 3 | 1989 | 1824 | 0.130 |
Why?
|
| alpha-Synuclein | 1 | 2022 | 773 | 0.130 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 309 | 0.130 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 1995 | 69 | 0.130 |
Why?
|
| Disease Models, Animal | 10 | 2022 | 18349 | 0.120 |
Why?
|
| Immunoblotting | 2 | 2016 | 1648 | 0.120 |
Why?
|
| Lung Neoplasms | 3 | 2018 | 13586 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2020 | 2202 | 0.120 |
Why?
|
| Drug Synergism | 3 | 2008 | 1760 | 0.120 |
Why?
|
| Muscle Contraction | 1 | 2010 | 1209 | 0.120 |
Why?
|
| Zebrafish | 3 | 2019 | 3035 | 0.120 |
Why?
|
| MAP Kinase Kinase 2 | 1 | 2014 | 93 | 0.120 |
Why?
|
| Patch-Clamp Techniques | 1 | 2017 | 927 | 0.120 |
Why?
|
| Cell Transformation, Viral | 2 | 1995 | 530 | 0.120 |
Why?
|
| Sulfhydryl Compounds | 1 | 2016 | 296 | 0.120 |
Why?
|
| Collagen Type III | 1 | 2014 | 92 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 1966 | 0.110 |
Why?
|
| Hyperparathyroidism | 1 | 2015 | 339 | 0.110 |
Why?
|
| Acid Phosphatase | 1 | 2014 | 141 | 0.110 |
Why?
|
| Aminoisobutyric Acids | 1 | 2014 | 39 | 0.110 |
Why?
|
| Mutant Proteins | 1 | 2016 | 488 | 0.110 |
Why?
|
| Glucose Transporter Type 4 | 2 | 2007 | 241 | 0.110 |
Why?
|
| Glycolysis | 4 | 2023 | 837 | 0.110 |
Why?
|
| Drosophila Proteins | 1 | 2023 | 1712 | 0.110 |
Why?
|
| Isotope Labeling | 1 | 2015 | 394 | 0.110 |
Why?
|
| Glucose Clamp Technique | 3 | 2007 | 263 | 0.110 |
Why?
|
| Peptide Fragments | 4 | 2016 | 5151 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 6 | 1999 | 1057 | 0.110 |
Why?
|
| Energy Intake | 2 | 2001 | 2146 | 0.110 |
Why?
|
| Deuterium Exchange Measurement | 1 | 2013 | 31 | 0.110 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2007 | 597 | 0.110 |
Why?
|
| Methylation | 1 | 2016 | 1078 | 0.110 |
Why?
|
| Thermodynamics | 1 | 2015 | 591 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 481 | 0.110 |
Why?
|
| Diphtheria Toxin | 2 | 1996 | 253 | 0.110 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 1 | 2013 | 57 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2023 | 2810 | 0.110 |
Why?
|
| History, 21st Century | 2 | 2024 | 1573 | 0.110 |
Why?
|
| Endoplasmic Reticulum | 1 | 2019 | 1133 | 0.110 |
Why?
|
| Receptors, Cell Surface | 3 | 1999 | 2819 | 0.100 |
Why?
|
| DNA Primers | 6 | 2004 | 2828 | 0.100 |
Why?
|
| Green Fluorescent Proteins | 2 | 2012 | 2065 | 0.100 |
Why?
|
| Diglycerides | 1 | 1993 | 176 | 0.100 |
Why?
|
| Proteome | 1 | 2022 | 1890 | 0.100 |
Why?
|
| Multiprotein Complexes | 2 | 2009 | 1110 | 0.100 |
Why?
|
| Cognition | 2 | 2021 | 7073 | 0.100 |
Why?
|
| Down-Regulation | 4 | 2023 | 2939 | 0.100 |
Why?
|
| Phenotype | 6 | 2021 | 16726 | 0.100 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2014 | 8648 | 0.100 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 267 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 1996 | 2846 | 0.100 |
Why?
|
| Neurogenesis | 1 | 2018 | 864 | 0.100 |
Why?
|
| Interleukin-13 | 1 | 2014 | 390 | 0.100 |
Why?
|
| Integrases | 2 | 2009 | 520 | 0.100 |
Why?
|
| Second Messenger Systems | 1 | 1992 | 203 | 0.100 |
Why?
|
| Rats, Wistar | 4 | 2005 | 1890 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 800 | 0.100 |
Why?
|
| Receptors, Thyroid Hormone | 2 | 2002 | 202 | 0.100 |
Why?
|
| Activin Receptors, Type II | 1 | 2012 | 122 | 0.090 |
Why?
|
| Sirtuin 1 | 2 | 2010 | 247 | 0.090 |
Why?
|
| Amino Acid Substitution | 3 | 2008 | 1743 | 0.090 |
Why?
|
| Phylogeny | 1 | 2019 | 2843 | 0.090 |
Why?
|
| Cell Cycle | 3 | 1997 | 2934 | 0.090 |
Why?
|
| Fetal Death | 1 | 1993 | 434 | 0.090 |
Why?
|
| Mitogens | 3 | 1996 | 229 | 0.090 |
Why?
|
| History, 20th Century | 2 | 2024 | 2766 | 0.090 |
Why?
|
| Aorta | 3 | 2006 | 2045 | 0.090 |
Why?
|
| Cholesterol | 5 | 2005 | 2914 | 0.090 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 2 | 2012 | 61 | 0.090 |
Why?
|
| Organ Size | 3 | 2014 | 2267 | 0.090 |
Why?
|
| Feedback, Physiological | 1 | 2013 | 482 | 0.090 |
Why?
|
| Macromolecular Substances | 5 | 2004 | 1435 | 0.090 |
Why?
|
| Immunohistochemistry | 6 | 2015 | 11095 | 0.090 |
Why?
|
| Transcription Factor CHOP | 1 | 2011 | 69 | 0.090 |
Why?
|
| Aging | 4 | 2015 | 8743 | 0.090 |
Why?
|
| Calcium | 4 | 2017 | 5792 | 0.090 |
Why?
|
| X-Rays | 1 | 2011 | 311 | 0.090 |
Why?
|
| NIH 3T3 Cells | 2 | 2010 | 669 | 0.090 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2011 | 279 | 0.090 |
Why?
|
| Cell Survival | 4 | 2010 | 5789 | 0.090 |
Why?
|
| Nephrectomy | 1 | 2015 | 930 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2010 | 41 | 0.090 |
Why?
|
| Nucleoproteins | 2 | 1988 | 110 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 2004 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2010 | 4585 | 0.090 |
Why?
|
| Molecular Conformation | 1 | 2011 | 540 | 0.090 |
Why?
|
| Biophysics | 1 | 2011 | 379 | 0.090 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1992 | 394 | 0.090 |
Why?
|
| Interleukin-4 | 1 | 2014 | 1156 | 0.090 |
Why?
|
| Oxidants | 2 | 2010 | 168 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2015 | 10478 | 0.090 |
Why?
|
| Cell Size | 1 | 2012 | 626 | 0.090 |
Why?
|
| Adiponectin | 2 | 2011 | 1117 | 0.090 |
Why?
|
| Scattering, Radiation | 1 | 2011 | 489 | 0.080 |
Why?
|
| Complement Activating Enzymes | 1 | 1989 | 22 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2020 | 2590 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2003 | 325 | 0.080 |
Why?
|
| Cricetinae | 7 | 1998 | 2423 | 0.080 |
Why?
|
| Alzheimer Disease | 2 | 2023 | 8759 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2010 | 157 | 0.080 |
Why?
|
| Vasodilation | 1 | 1993 | 967 | 0.080 |
Why?
|
| Intra-Abdominal Fat | 1 | 2014 | 625 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2015 | 981 | 0.080 |
Why?
|
| Molecular Biology | 1 | 2013 | 573 | 0.080 |
Why?
|
| Melanocytes | 1 | 2013 | 509 | 0.080 |
Why?
|
| Histone Acetyltransferases | 2 | 2003 | 335 | 0.080 |
Why?
|
| PPAR delta | 1 | 2009 | 40 | 0.080 |
Why?
|
| Muscular Diseases | 2 | 2018 | 553 | 0.080 |
Why?
|
| Body Mass Index | 5 | 2021 | 13053 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2003 | 1839 | 0.080 |
Why?
|
| Cytochrome-c Oxidase Deficiency | 1 | 2008 | 14 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 1995 | 945 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2010 | 2300 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2000 | 2748 | 0.080 |
Why?
|
| Motor Neurons | 2 | 2012 | 870 | 0.080 |
Why?
|
| Microcirculation | 1 | 1993 | 1281 | 0.080 |
Why?
|
| Mediator Complex Subunit 1 | 3 | 2003 | 31 | 0.080 |
Why?
|
| Myogenic Regulatory Factor 5 | 1 | 2008 | 27 | 0.080 |
Why?
|
| Stearoyl-CoA Desaturase | 2 | 1999 | 84 | 0.080 |
Why?
|
| Cycloheximide | 3 | 2013 | 341 | 0.080 |
Why?
|
| Monocytes | 1 | 1998 | 2605 | 0.080 |
Why?
|
| Plasma | 1 | 2012 | 585 | 0.080 |
Why?
|
| Adiposity | 2 | 2022 | 1895 | 0.080 |
Why?
|
| Superoxide Dismutase | 2 | 2012 | 596 | 0.080 |
Why?
|
| Vasodilator Agents | 1 | 1993 | 990 | 0.080 |
Why?
|
| Mitochondrial Myopathies | 1 | 2008 | 50 | 0.080 |
Why?
|
| Flow Cytometry | 3 | 2012 | 5902 | 0.080 |
Why?
|
| Presynaptic Terminals | 1 | 2010 | 302 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2015 | 1039 | 0.080 |
Why?
|
| Fungal Proteins | 1 | 1992 | 906 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2893 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2003 | 1525 | 0.080 |
Why?
|
| Body Composition | 3 | 2021 | 2462 | 0.070 |
Why?
|
| Corticosterone | 1 | 1989 | 301 | 0.070 |
Why?
|
| RNA-Binding Proteins | 3 | 2006 | 1891 | 0.070 |
Why?
|
| Anaerobic Threshold | 1 | 2008 | 52 | 0.070 |
Why?
|
| Ketones | 1 | 2009 | 183 | 0.070 |
Why?
|
| Heterozygote | 3 | 2009 | 2798 | 0.070 |
Why?
|
| Precipitin Tests | 2 | 2003 | 816 | 0.070 |
Why?
|
| Drug Design | 1 | 2013 | 1046 | 0.070 |
Why?
|
| DNA, Single-Stranded | 1 | 1990 | 351 | 0.070 |
Why?
|
| Multigene Family | 3 | 2005 | 1081 | 0.070 |
Why?
|
| Keratinocytes | 3 | 1997 | 876 | 0.070 |
Why?
|
| Choristoma | 1 | 2009 | 205 | 0.070 |
Why?
|
| Retinal Vessels | 1 | 1993 | 864 | 0.070 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2007 | 20 | 0.070 |
Why?
|
| Phosphothreonine | 1 | 2007 | 62 | 0.070 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2001 | 619 | 0.070 |
Why?
|
| Co-Repressor Proteins | 1 | 2008 | 190 | 0.070 |
Why?
|
| Microscopy, Electron | 2 | 2018 | 2560 | 0.070 |
Why?
|
| Lipids | 4 | 2009 | 3345 | 0.070 |
Why?
|
| Complement Pathway, Alternative | 3 | 1993 | 113 | 0.070 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2005 | 1683 | 0.070 |
Why?
|
| Embryo, Nonmammalian | 1 | 2010 | 910 | 0.070 |
Why?
|
| Brain | 6 | 2023 | 27362 | 0.070 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 1494 | 0.070 |
Why?
|
| Reference Values | 5 | 1997 | 4939 | 0.070 |
Why?
|
| Mice, Inbred mdx | 1 | 2007 | 90 | 0.070 |
Why?
|
| RNA Interference | 4 | 2013 | 2832 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2018 | 2956 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2008 | 193 | 0.070 |
Why?
|
| Epinephrine | 2 | 2006 | 794 | 0.070 |
Why?
|
| Thinness | 3 | 2014 | 483 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta-3 | 2 | 2017 | 63 | 0.070 |
Why?
|
| Cell Cycle Proteins | 2 | 2001 | 3445 | 0.070 |
Why?
|
| Hydrogen Peroxide | 2 | 2010 | 741 | 0.070 |
Why?
|
| Genes, ras | 3 | 2008 | 663 | 0.070 |
Why?
|
| Weight Gain | 3 | 2014 | 2359 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2011 | 10763 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 294 | 0.070 |
Why?
|
| Gene Targeting | 4 | 2001 | 841 | 0.070 |
Why?
|
| Blotting, Western | 4 | 2012 | 5028 | 0.070 |
Why?
|
| Body Weight | 5 | 2009 | 4627 | 0.070 |
Why?
|
| Tyrosine | 3 | 1996 | 1427 | 0.070 |
Why?
|
| Cyclic CMP | 1 | 2006 | 6 | 0.070 |
Why?
|
| Genes, Mitochondrial | 1 | 2006 | 59 | 0.070 |
Why?
|
| CREB-Binding Protein | 1 | 2006 | 147 | 0.070 |
Why?
|
| Catalase | 1 | 2006 | 215 | 0.070 |
Why?
|
| Apolipoproteins C | 1 | 2006 | 59 | 0.070 |
Why?
|
| Mice, Inbred Strains | 4 | 2008 | 1769 | 0.070 |
Why?
|
| Mice, Mutant Strains | 4 | 2014 | 1754 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1996 | 705 | 0.070 |
Why?
|
| Reference Standards | 1 | 2010 | 1014 | 0.070 |
Why?
|
| Receptors, Cholinergic | 1 | 2007 | 244 | 0.060 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 915 | 0.060 |
Why?
|
| Mitochondria, Liver | 1 | 2006 | 190 | 0.060 |
Why?
|
| Extracellular Matrix | 2 | 2024 | 1738 | 0.060 |
Why?
|
| Alleles | 4 | 2020 | 6894 | 0.060 |
Why?
|
| Histones | 1 | 2016 | 2601 | 0.060 |
Why?
|
| Apolipoproteins A | 1 | 2006 | 96 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2005 | 4149 | 0.060 |
Why?
|
| Neovascularization, Pathologic | 3 | 1990 | 2631 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 1997 | 257 | 0.060 |
Why?
|
| Iodide Peroxidase | 1 | 2007 | 295 | 0.060 |
Why?
|
| Societies, Scientific | 1 | 2006 | 223 | 0.060 |
Why?
|
| Glucagon | 2 | 2005 | 535 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 662 | 0.060 |
Why?
|
| Glutathione Peroxidase | 1 | 2006 | 259 | 0.060 |
Why?
|
| Protein Kinases | 1 | 1992 | 1611 | 0.060 |
Why?
|
| Nitriles | 1 | 2010 | 980 | 0.060 |
Why?
|
| Response Elements | 3 | 2001 | 308 | 0.060 |
Why?
|
| Models, Animal | 1 | 2012 | 2122 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1994 | 2433 | 0.060 |
Why?
|
| Endothelium | 3 | 1986 | 768 | 0.060 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 4 | 1998 | 221 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2000 | 354 | 0.060 |
Why?
|
| Sodium Glutamate | 3 | 1993 | 22 | 0.060 |
Why?
|
| Complement Factor B | 2 | 1996 | 57 | 0.060 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2005 | 63 | 0.060 |
Why?
|
| Exons | 4 | 2003 | 2394 | 0.060 |
Why?
|
| Actins | 4 | 1992 | 2064 | 0.060 |
Why?
|
| Sarcopenia | 1 | 2009 | 378 | 0.060 |
Why?
|
| Plasmids | 4 | 2005 | 2269 | 0.060 |
Why?
|
| Serine | 2 | 2000 | 831 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 4786 | 0.060 |
Why?
|
| Appetite Regulation | 1 | 2004 | 84 | 0.060 |
Why?
|
| Genetic Markers | 1 | 2010 | 2603 | 0.060 |
Why?
|
| Diabetic Retinopathy | 1 | 1993 | 1300 | 0.060 |
Why?
|
| Basal Ganglia Diseases | 1 | 2004 | 145 | 0.060 |
Why?
|
| Flavonoids | 2 | 1998 | 447 | 0.060 |
Why?
|
| Apoptosis | 2 | 2018 | 9527 | 0.060 |
Why?
|
| Rats, Mutant Strains | 1 | 2003 | 60 | 0.060 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2004 | 73 | 0.060 |
Why?
|
| Interleukin-6 | 2 | 2018 | 3229 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 1995 | 3056 | 0.050 |
Why?
|
| Sciatic Nerve | 1 | 1987 | 628 | 0.050 |
Why?
|
| RNA | 4 | 1997 | 2722 | 0.050 |
Why?
|
| Sweden | 1 | 2006 | 1382 | 0.050 |
Why?
|
| Cattle | 4 | 1999 | 3819 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2006 | 542 | 0.050 |
Why?
|
| E1A-Associated p300 Protein | 2 | 2003 | 125 | 0.050 |
Why?
|
| Peptides | 1 | 2015 | 4354 | 0.050 |
Why?
|
| Models, Genetic | 3 | 2004 | 3447 | 0.050 |
Why?
|
| HeLa Cells | 6 | 2009 | 3074 | 0.050 |
Why?
|
| Glucokinase | 1 | 2003 | 99 | 0.050 |
Why?
|
| Physical Endurance | 2 | 2016 | 369 | 0.050 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1250 | 0.050 |
Why?
|
| Creatine Kinase, MM Form | 1 | 2002 | 10 | 0.050 |
Why?
|
| Azoxymethane | 1 | 2002 | 32 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 4 | 1 | 2003 | 75 | 0.050 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 1339 | 0.050 |
Why?
|
| Mitochondrial Diseases | 1 | 2006 | 344 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2006 | 3806 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2006 | 1104 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 1998 | 1142 | 0.050 |
Why?
|
| Substrate Cycling | 1 | 2022 | 7 | 0.050 |
Why?
|
| Epithelium | 2 | 2005 | 1607 | 0.050 |
Why?
|
| Cross-Over Studies | 2 | 2021 | 2107 | 0.050 |
Why?
|
| Myoglobin | 1 | 2002 | 158 | 0.050 |
Why?
|
| Citric Acid Cycle | 1 | 2023 | 234 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 1995 | 4428 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 4 | 1997 | 792 | 0.050 |
Why?
|
| Calcineurin | 1 | 2003 | 235 | 0.050 |
Why?
|
| Restriction Mapping | 3 | 1995 | 849 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 1995 | 749 | 0.050 |
Why?
|
| Sirtuins | 1 | 2005 | 322 | 0.050 |
Why?
|
| Muscle Fatigue | 1 | 2002 | 96 | 0.050 |
Why?
|
| Locomotion | 1 | 2024 | 388 | 0.050 |
Why?
|
| Premenopause | 2 | 1997 | 1039 | 0.050 |
Why?
|
| Peptide Initiation Factors | 1 | 2001 | 53 | 0.050 |
Why?
|
| Acetyltransferases | 1 | 2003 | 231 | 0.050 |
Why?
|
| Dexamethasone | 3 | 2000 | 1965 | 0.050 |
Why?
|
| Regional Blood Flow | 2 | 2016 | 1500 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 2892 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 1667 | 0.050 |
Why?
|
| Isoproterenol | 3 | 1997 | 398 | 0.050 |
Why?
|
| Dopamine beta-Hydroxylase | 2 | 1998 | 74 | 0.050 |
Why?
|
| PPAR alpha | 2 | 2014 | 177 | 0.050 |
Why?
|
| Heparin | 2 | 1986 | 1636 | 0.050 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2012 | 1475 | 0.050 |
Why?
|
| Substrate Specificity | 2 | 1999 | 1751 | 0.050 |
Why?
|
| Butyric Acid | 2 | 1993 | 52 | 0.050 |
Why?
|
| Adenocarcinoma | 1 | 1998 | 6395 | 0.050 |
Why?
|
| Simian virus 40 | 3 | 1992 | 292 | 0.040 |
Why?
|
| Enzymes | 2 | 1998 | 254 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2013 | 1319 | 0.040 |
Why?
|
| Enzyme Inhibitors | 4 | 2004 | 3728 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2021 | 2885 | 0.040 |
Why?
|
| Epididymis | 2 | 2017 | 227 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2002 | 684 | 0.040 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 838 | 0.040 |
Why?
|
| Blotting, Southern | 2 | 1992 | 775 | 0.040 |
Why?
|
| Carcinogens | 1 | 2002 | 453 | 0.040 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 2000 | 100 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 2634 | 0.040 |
Why?
|
| Nuclear Receptor Coactivator 1 | 1 | 1999 | 42 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2004 | 633 | 0.040 |
Why?
|
| Angiopoietins | 1 | 2000 | 86 | 0.040 |
Why?
|
| Time Factors | 8 | 2005 | 40220 | 0.040 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 1998 | 367 | 0.040 |
Why?
|
| Butyrates | 2 | 1993 | 167 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 2003 | 1090 | 0.040 |
Why?
|
| DNA Probes | 2 | 2001 | 542 | 0.040 |
Why?
|
| Biology | 1 | 2022 | 292 | 0.040 |
Why?
|
| Gene Silencing | 2 | 2005 | 1505 | 0.040 |
Why?
|
| Linoleic Acids, Conjugated | 1 | 1999 | 13 | 0.040 |
Why?
|
| NF-E2-Related Factor 1 | 1 | 1999 | 21 | 0.040 |
Why?
|
| Nuclear Respiratory Factor 1 | 1 | 1999 | 23 | 0.040 |
Why?
|
| Arachidonic Acids | 1 | 2020 | 296 | 0.040 |
Why?
|
| Molecular Weight | 4 | 1989 | 2173 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2010 | 3713 | 0.040 |
Why?
|
| Prostaglandin D2 | 2 | 1999 | 108 | 0.040 |
Why?
|
| DNA, Complementary | 3 | 1999 | 1989 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2024 | 703 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2021 | 217 | 0.040 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2001 | 309 | 0.040 |
Why?
|
| Adrenergic beta-Agonists | 2 | 1998 | 347 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2001 | 2909 | 0.040 |
Why?
|
| Feedback | 1 | 2003 | 799 | 0.040 |
Why?
|
| Neuropeptide Y | 2 | 1998 | 194 | 0.040 |
Why?
|
| Coenzymes | 1 | 2019 | 101 | 0.040 |
Why?
|
| Azo Compounds | 1 | 1999 | 116 | 0.040 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1997 | 826 | 0.040 |
Why?
|
| Mutation, Missense | 1 | 2008 | 2592 | 0.040 |
Why?
|
| MicroRNAs | 1 | 2015 | 3803 | 0.040 |
Why?
|
| Cell Dedifferentiation | 1 | 2019 | 125 | 0.040 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2000 | 213 | 0.040 |
Why?
|
| Adult | 13 | 2021 | 223646 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2003 | 737 | 0.040 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2000 | 360 | 0.040 |
Why?
|
| Thermosensing | 1 | 2018 | 56 | 0.040 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2020 | 368 | 0.040 |
Why?
|
| Leukotriene B4 | 1 | 1999 | 281 | 0.040 |
Why?
|
| Ion Transport | 1 | 2019 | 322 | 0.040 |
Why?
|
| Yeasts | 1 | 1999 | 279 | 0.040 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2003 | 748 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 1996 | 863 | 0.040 |
Why?
|
| src Homology Domains | 1 | 1999 | 361 | 0.040 |
Why?
|
| Troponin I | 1 | 2002 | 662 | 0.040 |
Why?
|
| Acyltransferases | 2 | 2005 | 306 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2000 | 493 | 0.040 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1997 | 138 | 0.040 |
Why?
|
| Transcription Factor DP1 | 1 | 1997 | 136 | 0.040 |
Why?
|
| Young Adult | 4 | 2021 | 60066 | 0.040 |
Why?
|
| Amyloid beta-Peptides | 2 | 2023 | 3914 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 542 | 0.040 |
Why?
|
| Behavior, Animal | 3 | 2021 | 1862 | 0.040 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 1997 | 9 | 0.040 |
Why?
|
| Purine Nucleotides | 1 | 2017 | 27 | 0.040 |
Why?
|
| beta Catenin | 1 | 2002 | 1047 | 0.040 |
Why?
|
| Complement C3 | 2 | 1996 | 434 | 0.040 |
Why?
|
| Skin | 2 | 2009 | 4505 | 0.040 |
Why?
|
| Electric Stimulation | 1 | 2002 | 1741 | 0.040 |
Why?
|
| Inguinal Canal | 1 | 2017 | 71 | 0.040 |
Why?
|
| Carboxypeptidase H | 1 | 1996 | 9 | 0.040 |
Why?
|
| Immobilization | 1 | 1998 | 229 | 0.040 |
Why?
|
| Agouti Signaling Protein | 1 | 1996 | 22 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 1997 | 52 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1977 | 315 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 1997 | 270 | 0.030 |
Why?
|
| In Situ Hybridization | 3 | 2010 | 1904 | 0.030 |
Why?
|
| Chimera | 3 | 1999 | 454 | 0.030 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2000 | 326 | 0.030 |
Why?
|
| Serum Albumin | 1 | 2020 | 677 | 0.030 |
Why?
|
| Catecholamines | 1 | 1998 | 389 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2000 | 901 | 0.030 |
Why?
|
| Carbazoles | 1 | 2018 | 230 | 0.030 |
Why?
|
| Kindling, Neurologic | 1 | 1996 | 24 | 0.030 |
Why?
|
| Glycine | 1 | 2020 | 672 | 0.030 |
Why?
|
| Arginine | 1 | 2000 | 932 | 0.030 |
Why?
|
| Carboxypeptidases | 1 | 1996 | 121 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1997 | 6340 | 0.030 |
Why?
|
| Abelson murine leukemia virus | 1 | 1995 | 41 | 0.030 |
Why?
|
| Tretinoin | 1 | 1999 | 525 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 1996 | 243 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 1995 | 5863 | 0.030 |
Why?
|
| Genetic Variation | 2 | 2005 | 6610 | 0.030 |
Why?
|
| Lipoprotein Lipase | 1 | 1996 | 133 | 0.030 |
Why?
|
| Action Potentials | 1 | 2003 | 1838 | 0.030 |
Why?
|
| Integrins | 1 | 2020 | 842 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1997 | 327 | 0.030 |
Why?
|
| Oncogenes | 2 | 1994 | 1234 | 0.030 |
Why?
|
| Astrocytes | 1 | 2023 | 1350 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2008 | 5341 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 1896 | 0.030 |
Why?
|
| Career Choice | 1 | 2002 | 769 | 0.030 |
Why?
|
| NAD | 2 | 2013 | 618 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 1996 | 274 | 0.030 |
Why?
|
| Carboxy-Lyases | 1 | 1975 | 85 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 1837 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2015 | 58 | 0.030 |
Why?
|
| Aspergillus | 1 | 1975 | 95 | 0.030 |
Why?
|
| Food | 1 | 2000 | 768 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2023 | 3161 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 1996 | 352 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1998 | 637 | 0.030 |
Why?
|
| Apolipoproteins B | 1 | 1996 | 386 | 0.030 |
Why?
|
| Ceramides | 1 | 1996 | 203 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 1997 | 348 | 0.030 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2014 | 15 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2003 | 21207 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2004 | 2463 | 0.030 |
Why?
|
| Papilloma | 1 | 1995 | 143 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2005 | 1673 | 0.030 |
Why?
|
| Hyperglycemia | 2 | 2019 | 1388 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 1994 | 220 | 0.030 |
Why?
|
| Metallothionein | 1 | 1994 | 62 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1997 | 428 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 1461 | 0.030 |
Why?
|
| Melanoma | 1 | 2013 | 5706 | 0.030 |
Why?
|
| Blood | 1 | 1996 | 599 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2006 | 2057 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 1998 | 663 | 0.030 |
Why?
|
| Keratins | 1 | 1995 | 499 | 0.030 |
Why?
|
| Epidermal Growth Factor | 1 | 1996 | 697 | 0.030 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 1994 | 139 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2001 | 2222 | 0.030 |
Why?
|
| Antigens, Differentiation | 1 | 1997 | 921 | 0.030 |
Why?
|
| Chemotactic Factors | 1 | 1994 | 197 | 0.030 |
Why?
|
| Dicumarol | 1 | 2013 | 9 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 1994 | 458 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2001 | 1346 | 0.030 |
Why?
|
| Genes, Viral | 2 | 1992 | 655 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2008 | 9384 | 0.030 |
Why?
|
| Guinea Pigs | 1 | 1995 | 1309 | 0.030 |
Why?
|
| Retroviridae | 2 | 2005 | 846 | 0.030 |
Why?
|
| Cell Death | 1 | 2018 | 1680 | 0.030 |
Why?
|
| Osteopetrosis | 1 | 1992 | 42 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2000 | 944 | 0.030 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2018 | 1117 | 0.030 |
Why?
|
| Drug Interactions | 1 | 1997 | 1419 | 0.030 |
Why?
|
| Gametogenesis | 1 | 1992 | 27 | 0.030 |
Why?
|
| B-Lymphocytes | 2 | 2004 | 4793 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1992 | 53 | 0.030 |
Why?
|
| Homozygote | 2 | 1998 | 1779 | 0.030 |
Why?
|
| Cinnamates | 1 | 1992 | 59 | 0.030 |
Why?
|
| Glycerol | 1 | 1993 | 274 | 0.030 |
Why?
|
| Neutralization Tests | 1 | 1994 | 739 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 1994 | 386 | 0.030 |
Why?
|
| Cricetulus | 2 | 1989 | 812 | 0.030 |
Why?
|
| PC12 Cells | 1 | 1992 | 317 | 0.020 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2000 | 1613 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 455 | 0.020 |
Why?
|
| Glycerol Kinase | 1 | 1991 | 15 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2021 | 2055 | 0.020 |
Why?
|
| Histamine | 1 | 1993 | 496 | 0.020 |
Why?
|
| Culture Techniques | 1 | 1992 | 530 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 1994 | 605 | 0.020 |
Why?
|
| Glycosylation | 1 | 1995 | 1100 | 0.020 |
Why?
|
| Alprostadil | 1 | 1991 | 86 | 0.020 |
Why?
|
| Chromatin | 1 | 2003 | 2981 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 1994 | 4568 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 2014 | 0.020 |
Why?
|
| Protein Kinase C | 1 | 1996 | 1207 | 0.020 |
Why?
|
| Cytoplasm | 1 | 1996 | 1505 | 0.020 |
Why?
|
| Chemotaxis | 2 | 1986 | 600 | 0.020 |
Why?
|
| Surface Plasmon Resonance | 1 | 2012 | 272 | 0.020 |
Why?
|
| Capillary Permeability | 1 | 1995 | 772 | 0.020 |
Why?
|
| Insulin Infusion Systems | 1 | 1993 | 221 | 0.020 |
Why?
|
| United States | 2 | 2024 | 73039 | 0.020 |
Why?
|
| Y-Box-Binding Protein 1 | 1 | 1991 | 41 | 0.020 |
Why?
|
| Sulfides | 1 | 2012 | 171 | 0.020 |
Why?
|
| Colorectal Neoplasms | 2 | 2002 | 6975 | 0.020 |
Why?
|
| Placenta | 1 | 2000 | 1725 | 0.020 |
Why?
|
| Eating | 1 | 1998 | 1542 | 0.020 |
Why?
|
| NFI Transcription Factors | 1 | 1991 | 49 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2013 | 257 | 0.020 |
Why?
|
| Forecasting | 1 | 2000 | 2945 | 0.020 |
Why?
|
| Point Mutation | 1 | 1996 | 1596 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2021 | 2735 | 0.020 |
Why?
|
| Paralysis | 1 | 2012 | 250 | 0.020 |
Why?
|
| Ionomycin | 1 | 2010 | 110 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1998 | 1408 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2003 | 2334 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1990 | 212 | 0.020 |
Why?
|
| Liver Neoplasms | 2 | 2003 | 4363 | 0.020 |
Why?
|
| Lymphopenia | 1 | 1992 | 300 | 0.020 |
Why?
|
| Ephedrine | 1 | 1990 | 52 | 0.020 |
Why?
|
| Lymphocyte Activation | 2 | 1998 | 5505 | 0.020 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1989 | 73 | 0.020 |
Why?
|
| Kainic Acid | 1 | 2010 | 203 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1995 | 2683 | 0.020 |
Why?
|
| Sex Factors | 1 | 2024 | 10632 | 0.020 |
Why?
|
| Protein Stability | 1 | 2012 | 579 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1997 | 1802 | 0.020 |
Why?
|
| Prostatic Neoplasms | 2 | 2004 | 11101 | 0.020 |
Why?
|
| Body Fluids | 1 | 2011 | 321 | 0.020 |
Why?
|
| Demecolcine | 2 | 1979 | 18 | 0.020 |
Why?
|
| Griseofulvin | 2 | 1979 | 10 | 0.020 |
Why?
|
| CHO Cells | 1 | 1992 | 1379 | 0.020 |
Why?
|
| Body Constitution | 1 | 2009 | 273 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 455 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1993 | 2179 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 1972 | 0.020 |
Why?
|
| Bezafibrate | 1 | 2008 | 14 | 0.020 |
Why?
|
| NF-kappa B | 1 | 1997 | 2494 | 0.020 |
Why?
|
| Uteroglobin | 1 | 2008 | 56 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2540 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2013 | 2486 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 1990 | 191 | 0.020 |
Why?
|
| Fertility | 1 | 1993 | 771 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1996 | 1767 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 2009 | 0.020 |
Why?
|
| Citrate (si)-Synthase | 1 | 2008 | 48 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1988 | 116 | 0.020 |
Why?
|
| Chick Embryo | 1 | 1990 | 975 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2003 | 8142 | 0.020 |
Why?
|
| Fluorescein Angiography | 1 | 1993 | 1086 | 0.020 |
Why?
|
| Indoles | 2 | 2012 | 1836 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 15662 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2002 | 10099 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1990 | 781 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2021 | 3445 | 0.020 |
Why?
|
| Photochemistry | 1 | 1988 | 238 | 0.020 |
Why?
|
| Neuronal Plasticity | 1 | 1996 | 1448 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2008 | 5704 | 0.020 |
Why?
|
| Fos-Related Antigen-2 | 2 | 1997 | 14 | 0.020 |
Why?
|
| Glycogen | 1 | 2008 | 252 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2021 | 3980 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1988 | 256 | 0.020 |
Why?
|
| Biological Assay | 1 | 1990 | 628 | 0.020 |
Why?
|
| Rabbits | 2 | 1999 | 4773 | 0.020 |
Why?
|
| Immune Sera | 1 | 1987 | 605 | 0.020 |
Why?
|
| Thyroid Neoplasms | 1 | 2000 | 2360 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 1901 | 0.020 |
Why?
|
| Adrenalectomy | 1 | 1989 | 348 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1986 | 548 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2021 | 12466 | 0.020 |
Why?
|
| Small Molecule Libraries | 1 | 2012 | 742 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 1998 | 455 | 0.020 |
Why?
|
| Proteomics | 1 | 2020 | 3912 | 0.020 |
Why?
|
| Biphenyl Compounds | 1 | 2011 | 1026 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2012 | 942 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2008 | 389 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 3840 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 1986 | 153 | 0.020 |
Why?
|
| Plasminogen Activators | 1 | 1986 | 199 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1987 | 513 | 0.020 |
Why?
|
| Polyomavirus | 1 | 1986 | 235 | 0.020 |
Why?
|
| Caffeine | 1 | 1990 | 703 | 0.020 |
Why?
|
| Early Growth Response Protein 2 | 1 | 2005 | 25 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 1987 | 796 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1989 | 1385 | 0.010 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 160 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3814 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2005 | 277 | 0.010 |
Why?
|
| Learning | 1 | 1994 | 1759 | 0.010 |
Why?
|
| Middle Aged | 9 | 2020 | 223487 | 0.010 |
Why?
|
| Memory | 1 | 1994 | 2207 | 0.010 |
Why?
|
| Uncoupling Agents | 1 | 2004 | 46 | 0.010 |
Why?
|
| NFATC Transcription Factors | 2 | 1998 | 393 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 1996 | 2593 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 2010 | 1191 | 0.010 |
Why?
|
| Kidney | 2 | 1995 | 7064 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 1996 | 3205 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1986 | 1305 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2021 | 6669 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 2005 | 205 | 0.010 |
Why?
|
| Diet | 2 | 2014 | 8089 | 0.010 |
Why?
|
| Glucose Intolerance | 1 | 2008 | 579 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 958 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2005 | 344 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2015 | 3080 | 0.010 |
Why?
|
| Mediator Complex | 1 | 2003 | 106 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 713 | 0.010 |
Why?
|
| Running | 1 | 2008 | 490 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 2003 | 333 | 0.010 |
Why?
|
| Denmark | 1 | 2005 | 776 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2005 | 462 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2005 | 577 | 0.010 |
Why?
|
| Genotype | 3 | 2005 | 13045 | 0.010 |
Why?
|
| Caloric Restriction | 1 | 2005 | 301 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 872 | 0.010 |
Why?
|
| Mice, Inbred DBA | 1 | 2003 | 624 | 0.010 |
Why?
|
| Echocardiography | 1 | 2015 | 5047 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1998 | 4530 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 1056 | 0.010 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 1887 | 0.010 |
Why?
|
| MyoD Protein | 1 | 2002 | 143 | 0.010 |
Why?
|
| Eukaryotic Initiation Factors | 1 | 2001 | 83 | 0.010 |
Why?
|
| Bucladesine | 1 | 1981 | 118 | 0.010 |
Why?
|
| Malate Dehydrogenase | 1 | 1981 | 40 | 0.010 |
Why?
|
| Vimentin | 1 | 1982 | 257 | 0.010 |
Why?
|
| Age Factors | 2 | 2015 | 18415 | 0.010 |
Why?
|
| Theophylline | 1 | 1981 | 133 | 0.010 |
Why?
|
| Peptide Biosynthesis | 1 | 1980 | 52 | 0.010 |
Why?
|
| Eukaryotic Initiation Factor-4E | 1 | 2001 | 112 | 0.010 |
Why?
|
| Fructose-Bisphosphate Aldolase | 1 | 1980 | 43 | 0.010 |
Why?
|
| Epilepsy | 1 | 1996 | 3326 | 0.010 |
Why?
|
| Aged | 7 | 2015 | 171502 | 0.010 |
Why?
|
| Lysine | 1 | 2005 | 1000 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 943 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 846 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2005 | 1997 | 0.010 |
Why?
|
| Swine | 3 | 1979 | 5997 | 0.010 |
Why?
|
| Peroxisome Proliferators | 1 | 1999 | 6 | 0.010 |
Why?
|
| Paired Box Transcription Factors | 1 | 2000 | 206 | 0.010 |
Why?
|
| Sebaceous Glands | 1 | 1999 | 42 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2005 | 1140 | 0.010 |
Why?
|
| Adolescent | 2 | 2021 | 89169 | 0.010 |
Why?
|
| Linoleic Acids | 1 | 1999 | 39 | 0.010 |
Why?
|
| Random Allocation | 1 | 2004 | 2395 | 0.010 |
Why?
|
| Macropodidae | 1 | 1979 | 12 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1980 | 412 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1999 | 226 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1999 | 136 | 0.010 |
Why?
|
| Base Pairing | 1 | 1999 | 139 | 0.010 |
Why?
|
| Zebrafish Proteins | 1 | 2005 | 1019 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1999 | 363 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1987 | 4620 | 0.010 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 1 | 1998 | 18 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 1998 | 97 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1983 | 1179 | 0.010 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 1999 | 225 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6316 | 0.010 |
Why?
|
| Culture Media | 1 | 1980 | 898 | 0.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 1998 | 58 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 30255 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1999 | 699 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2005 | 3623 | 0.010 |
Why?
|
| Cell Movement | 1 | 1990 | 5213 | 0.010 |
Why?
|
| Molecular Probes | 1 | 1999 | 309 | 0.010 |
Why?
|
| Dactinomycin | 1 | 1998 | 305 | 0.010 |
Why?
|
| Lipoproteins, LDL | 1 | 2001 | 644 | 0.010 |
Why?
|
| Dimerization | 1 | 1999 | 887 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1999 | 406 | 0.010 |
Why?
|
| Vinblastine | 1 | 1979 | 487 | 0.010 |
Why?
|
| Adrenergic beta-1 Receptor Agonists | 1 | 1997 | 14 | 0.010 |
Why?
|
| Longevity | 1 | 2005 | 1077 | 0.010 |
Why?
|
| Simvastatin | 1 | 1999 | 346 | 0.010 |
Why?
|
| Aurothioglucose | 1 | 1996 | 11 | 0.010 |
Why?
|
| Growth Hormone | 1 | 1999 | 573 | 0.010 |
Why?
|
| Dobutamine | 1 | 1997 | 116 | 0.010 |
Why?
|
| Intermediate Filament Proteins | 1 | 1997 | 261 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2005 | 4120 | 0.010 |
Why?
|
| Prostatectomy | 1 | 2004 | 1786 | 0.010 |
Why?
|
| Suppression, Genetic | 1 | 1996 | 190 | 0.010 |
Why?
|
| Nutritional Status | 1 | 2005 | 1628 | 0.010 |
Why?
|
| Restraint, Physical | 1 | 1998 | 185 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 1979 | 958 | 0.010 |
Why?
|
| Maleimides | 1 | 1996 | 112 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1998 | 777 | 0.010 |
Why?
|
| Treatment Failure | 1 | 2002 | 2661 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2000 | 581 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 1996 | 102 | 0.010 |
Why?
|
| Lipolysis | 1 | 1997 | 211 | 0.010 |
Why?
|
| Disease Progression | 2 | 2003 | 13668 | 0.010 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 1996 | 179 | 0.010 |
Why?
|
| Catechols | 1 | 1975 | 63 | 0.010 |
Why?
|
| Collagen | 1 | 1983 | 2645 | 0.010 |
Why?
|
| Adrenal Glands | 1 | 1998 | 557 | 0.010 |
Why?
|
| Dentate Gyrus | 1 | 1996 | 165 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2003 | 4034 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 2000 | 793 | 0.010 |
Why?
|
| Gene Dosage | 1 | 1999 | 1219 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2003 | 3620 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1999 | 1062 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2000 | 1394 | 0.010 |
Why?
|
| Prostaglandins | 1 | 1995 | 398 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 12840 | 0.010 |
Why?
|
| Hypoglycemia | 1 | 2001 | 895 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 1994 | 148 | 0.010 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1994 | 318 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1996 | 1266 | 0.010 |
Why?
|
| Protein Precursors | 1 | 1997 | 1135 | 0.010 |
Why?
|
| Tryptophan | 1 | 1975 | 482 | 0.010 |
Why?
|
| Hygromycin B | 1 | 1992 | 11 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1992 | 34 | 0.010 |
Why?
|
| Ovary | 1 | 1977 | 965 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2004 | 65379 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1228 | 0.010 |
Why?
|
| Propranolol | 1 | 1994 | 493 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1996 | 1049 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2005 | 3591 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1994 | 897 | 0.010 |
Why?
|
| Visual Pathways | 1 | 1996 | 557 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1992 | 302 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1993 | 446 | 0.010 |
Why?
|
| Baculoviridae | 1 | 1990 | 115 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1979 | 1266 | 0.010 |
Why?
|
| Sympathomimetics | 1 | 1990 | 57 | 0.010 |
Why?
|
| Secretory Rate | 1 | 1989 | 82 | 0.010 |
Why?
|
| Spleen | 1 | 1996 | 2296 | 0.010 |
Why?
|
| Light | 1 | 1996 | 1355 | 0.010 |
Why?
|
| Deoxyribonuclease I | 1 | 1990 | 228 | 0.010 |
Why?
|
| Adenoma | 1 | 2000 | 2159 | 0.010 |
Why?
|
| Drug Resistance, Microbial | 1 | 1992 | 830 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1989 | 383 | 0.000 |
Why?
|
| Intracellular Membranes | 1 | 1989 | 388 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 20762 | 0.000 |
Why?
|
| Axons | 1 | 1996 | 1677 | 0.000 |
Why?
|
| Solubility | 1 | 1989 | 1086 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2004 | 59626 | 0.000 |
Why?
|
| Biopsy | 1 | 1999 | 6792 | 0.000 |
Why?
|
| Embryo, Mammalian | 1 | 1992 | 1676 | 0.000 |
Why?
|
| Risk Factors | 1 | 2014 | 74944 | 0.000 |
Why?
|
| Psychomotor Performance | 1 | 1994 | 1892 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1995 | 2649 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2662 | 0.000 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 1999 | 3251 | 0.000 |
Why?
|
| Immunoassay | 1 | 1988 | 746 | 0.000 |
Why?
|
| Drug Combinations | 1 | 1990 | 2089 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1988 | 2474 | 0.000 |
Why?
|
| Transduction, Genetic | 1 | 1986 | 899 | 0.000 |
Why?
|
| Seizures | 1 | 1996 | 2998 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2008 | 36741 | 0.000 |
Why?
|
| Chickens | 1 | 1979 | 845 | 0.000 |
Why?
|
| Species Specificity | 1 | 1979 | 2415 | 0.000 |
Why?
|
| Child | 1 | 2000 | 80917 | 0.000 |
Why?
|